Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T05:18:28.831Z Has data issue: false hasContentIssue false

The importance of isolated thrombocytopenia on routine blood screening in psychiatric patients

Published online by Cambridge University Press:  13 June 2014

Gerard Waldron
Affiliation:
Three Bridges Regional Secure Unit, St Bernard's Hospital, Uxbridge Road, Middlesex UBI3EU, England
Ans J Schipperheijn
Affiliation:
Napsbury Hospital, Shenley Lane, London Colney, Hertfordshire AL2 1AA, England
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © Cambridge University Press 1999

References

1.George, JN, Shattil, SJ. The clinical importance of acquired abnormalities of platelet function. New Eng J Med 1991; 324(1): 2739.CrossRefGoogle ScholarPubMed
2.Storrie, MC, Scher, M, McGuire, J, Bokan, J. Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics. J Clin Psychiat 1978; 39: 779–81.Google ScholarPubMed
3.Ray, JG. Neuroleptic Malignant Syndrome associated with thrombocytopenia. J Internal Med 1997: 241; 245–7.CrossRefGoogle ScholarPubMed
4.Holt, RJ. Neuroleptic drug-induced changes in platelet levels. J Clin Psychopharmacology 1984: 4(3): 130–2.CrossRefGoogle ScholarPubMed
5.Assion, HJ, Kolbinger, HM, Rao, ML. Laux, G. Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine. Pharmacopsychiatry 1996; 29(6): 227–8.CrossRefGoogle ScholarPubMed
6.Lowy, A, Wilson, A, Sachdev, P, Lindeman, R. Disseminated intravascular coagulopathy and thrombocytopenia associated with clozapine-induced neuroleptic malignant syndrome. Aust NZ J Med 1995; 25: 368.CrossRefGoogle ScholarPubMed
7.Shawver, JR, Tarnowski, SM. Thrombocytopenia in prolonged chlorpromazine therapy. Am J Psychiatry 1960; 116: 845CrossRefGoogle ScholarPubMed
8.Holt, RJ. Neuroleptic drug-induced thrombocytopenia (abstract). Drug Intelligence Clinical Pharmacology 1983; 17: 437.Google Scholar
9.Mahmood, T, Silverstone, T, Spittle, B. Risperidone appears safe in patients with anti-psychotic blood dyserasias. Int Clin Psychopharmacology 1996; 11: 53–4.CrossRefGoogle Scholar
10.Young, A, Kehoe, R. Two cases of agranulocytosis on addition of a butryphenone to a longstanding course of phenothiazine treatment. Br J Psychiatry 1989;154:710–2.CrossRefGoogle ScholarPubMed